Schumer Demanded FDA Crackdown on Illicit Vapes

The senator is calling for an investigation into unauthorized nicotine products that dominate current market sales.

Updated on Sept. 27, 2026 in Asthma

Isometric editorial illustration of a generic disposable e-cigarette device next to a laboratory flask, representing a regulatory investigation.
Senator Chuck Schumer has called on the FDA to launch a formal investigation into the prevalence of unauthorized e-cigarette products currently dominating the U.S. market. AI Illustration. Upload story photo >

Live Poll

Should the federal government increase regulation of imported electronic cigarettes and nicotine products?

Senator Chuck Schumer has called on the FDA to report on the prevalence of illicit e-cigarettes, noting that unauthorized products account for 70% of all e-cigarette sales in the United States. He is requesting a formal investigation into whether manufacturers are using chemical substitutes to bypass regulatory oversight.

Why it matters

The request follows concerns that staffing cuts within the agency have hindered its ability to monitor and remove these products from the market. Addressing this oversight is critical given the high volume of unauthorized disposable vapes, which constitute 97% of that market segment.

Current market analysis indicates that unauthorized products now represent 70% of total U.S. e-cigarette sales and 97% of the disposable market. The FDA must now determine how these products enter the supply chain and if chemical modifications are being used to mask their identity.

The players

Chuck Schumer

United States Senator who is overseeing the request for federal regulatory action against unauthorized nicotine products.

Kyle Diamantas

Acting Commissioner of the Food and Drug Administration, the agency responsible for public health and product safety regulation.

The details

The FDA is being urged to utilize its existing authority to identify and remove unlawful products from circulation. The inquiry focuses on whether manufacturers use chemical substitutes to alter the molecular signature of nicotine products to circumvent regulatory screening processes. This effort aims to stabilize oversight that may have been compromised by institutional staffing cuts enacted in 2025.

Timeline

  1. 2025: The Trump administration implemented FDA staffing cuts.

  2. September 27, 2026: Senator Chuck Schumer sent the request letter to the FDA.

  3. October 27, 2026: Deadline for the FDA to provide a formal response.

Health Landscape

This request highlights the ongoing challenges in regulating the nicotine market following the 2025 FDA staffing cuts. The move underscores the difficulty of maintaining consistent oversight of consumer products in an evolving regulatory environment.

Given the high percentage of unauthorized products currently available, it is vital to be aware that these vapes may contain undisclosed chemical substances. If you have concerns about the safety of nicotine products you use, consult your physician to discuss health risks and cessation strategies.

The takeaway

The prevalence of unauthorized vaping products highlights a significant gap in current federal market oversight. Readers should remain cautious regarding unregulated tobacco products and speak with a healthcare provider about safe, approved alternatives for managing nicotine dependence.

What happens next

The FDA is expected to provide a formal report and response to the letter by October 27, 2026.

Further reading

Learn more about the lung health implications of unregulated inhalants in our guide to Asthma.

Source note: This article includes information reported by Daily News.

Live Poll

Should the federal government increase regulation of imported electronic cigarettes and nicotine products?